An assessment of the use of implanon® in three community services

Journal of Family Planning and Reproductive Health Care

Volumn 28, Issue 4, 2002, Pages 193-196

  Smith, Amanda ^a,b   Reuter, Simone ^c,d  

^a North Derbyshire Contraception   (United Kingdom)

^b Ctrl Nottinghamshire Fam Plan   (United Kingdom)

^c Doncaster Family Planning Service   (United Kingdom)

^d North Derbyshire Sexual Hlth Serv   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ETONOGESTREL; 3 KETO DESOGESTREL; 3-KETO-DESOGESTREL; CONTRACEPTIVE AGENT; DESOGESTREL; VINYL DERIVATIVE;

ABDOMINAL PAIN; ACNE; ADOLESCENT; ADULT; ARTICLE; BREAST TENDERNESS; CLINICAL PRACTICE; CONTRACEPTION; DEPRESSION; DRUG IMPLANT; FATIGUE; FEMALE; HEADACHE; HEALTH CARE QUALITY; HEALTH SERVICE; HUMAN; INFLAMMATION; INJECTION PAIN; LIBIDO DISORDER; MAJOR CLINICAL STUDY; MOOD DISORDER; PATIENT COMPLIANCE; PATIENT COUNSELING; PREGNANCY; VAGINA BLEEDING; WEIGHT GAIN; DEVICE REMOVAL; HEALTH CENTER; MIDDLE AGED; PATIENT ATTITUDE; RETROSPECTIVE STUDY;

ADOLESCENT; ADULT; COMMUNITY HEALTH CENTERS; CONTRACEPTIVE AGENTS, FEMALE; DESOGESTREL; DEVICE REMOVAL; DRUG IMPLANTS; FEMALE; HUMANS; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; RETROSPECTIVE STUDIES; VINYL COMPOUNDS;

EID: 0036771643     PISSN: 14711893     EISSN: None     Source Type: Journal    
DOI: 10.1783/147118902101196540     Document Type: Article

References (14)

1. Croxatto HB, Makarainen L. The pharmacodynamics and efficacy of Implanon®, an overview of the data. Contraception 1998; 58(Suppl.): 91S-97S.
2. Croxatto HB, Urbancsek J, Massai R, et al. A multicentre efficacy and safety study of the single contraceptive implant Implanon®. Implanon® Study Group. Hum Reprod 1999; 14(4): 976-981.
3. Edwards J, Moore A. Implanon®; a review of clinical studies. Br J Fam Plann 1999; 24(4)(Suppl.): 3-16.
4. Phillips CJ. An economic review of contraceptive implants in the UK. EBM in Practice 1999; September: 3-16.
5. IMPLANON® Training Manual for Clinicians. Organon Laboratories Ltd, Cambridge Scientific Park, Milton Road, Cambridge, CB4 0FL. UK. Tel: +44 (0) 1233 432700.
6. Oloto E, Mascharenhas L. Subdermal contraceptive implants (FACT). Br J Fam Plann 2000; 26(3): 171-174.
7. Mascharenhas L. Insertion and removal of Implanon®. Contraception 1998; 58(Suppl.): 79S-83S.
8. Altman DG. Practical Statistics for Medical Research. London: Chapman & Hall, 1991.
9. Cox DR. Regression models and life tables. J Roy Stat Soc B 1972; 34: 187-220.
10. Glasier A. Implantable contraceptives for women: Effectiveness, discontinuation rates, return of fertility, and outcome of pregnancies. Contraception 2002; 65: 29-37.
11. Brache V, Faundes F, Alvarez F, et al. Nonmenstrual adverse events during use of implantable contraceptives for women: Data from clinical trials. Contraception 2002; 65: 63-74.
12. Sanfilippo J, Creatsas G. Paediatric and adolescent gynaecology. In: Kubba A, Sanfillipo J, Hampton N (eds), Contraception and Office Gynecology. London: WB Saunders, 1999; 265-281.
13. Hickey M, d'Arcangues C. Vaginal bleeding disturbances and implantable contraceptives. Contraception 2002; 65: 75-84.
14. Croxatto HB. Clinical profile of Implanon®: a single rod etonogestrel contraceptive implant. Eur J Contracept Reprod Health Care 2000; 5(Suppl. 2): 21-28.